<DOC>
	<DOCNO>NCT00347841</DOCNO>
	<brief_summary>To evaluate IOP-lowering efficacy bimatoprost 0.03 % patient find low-responders latanoprost therapy .</brief_summary>
	<brief_title>Efficacy Bimatoprost 0.03 % Patients Who Are Low-Responders Latanoprost</brief_title>
	<detailed_description />
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>· Male female &gt; 18 year age Documented lowresponder latanoprost therapy delineate outline . Diagnosis openangle glaucoma ocular hypertension Ability provide inform consent likely complete study visit · Known contraindication bimatoprost component study medication Uncontrolled systemic disease Active ocular disease glaucoma ocular hypertension Required use ocular medication study medication study ( intermittent use artificial tear solution permit ) History intraocular surgery within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>